{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:41:22Z","timestamp":1790102482035,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s42000-025-00672-0","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:19:15Z","timestamp":1747865955000},"page":"891-895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spontaneous restoration of premature ovarian insufficiency and conception in a patient with glycogen storage disease type 1b managed with empagliflozin"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6898-1357","authenticated-orcid":false,"given":"Maria Evangelia","family":"Koloutsou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Yavropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Makrilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"9","key":"672_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1515\/jpem-2023-0127","volume":"36","author":"T Zelei","year":"2023","unstructured":"Zelei T, Kovacs S, Finn P, Nagy D, Sikirica V, Carlson KB et al (2023) Systematic literature review of the epidemiology of glycogen storage disease type 1a. J Pediatr Endocrinol Metab 36(9):809\u2013817. https:\/\/doi.org\/10.1515\/jpem-2023-0127","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5133","key":"672_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.8211187","volume":"262","author":"KJ Lei","year":"1993","unstructured":"Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY (1993) Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science 262(5133):580\u2013583. https:\/\/doi.org\/10.1126\/science.8211187","journal-title":"Science"},{"issue":"2","key":"672_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1006\/mgme.2001.3179","volume":"73","author":"AR Janecke","year":"2001","unstructured":"Janecke AR, Mayatepek E, Utermann G (2001) Molecular genetics of type 1 glycogen storage disease. Mol Genet Metab 73(2):117\u2013125. https:\/\/doi.org\/10.1006\/mgme.2001.3179","journal-title":"Mol Genet Metab"},{"key":"672_CR4","doi-asserted-by":"publisher","unstructured":"Rajas F, Gautier-Stein A, Mithieux G (2019) Glucose-6 phosphate, A central hub for liver carbohydrate metabolism. Metabolites 9(12). https:\/\/doi.org\/10.3390\/metabo9120282","DOI":"10.3390\/metabo9120282"},{"issue":"25","key":"672_CR5","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.3748\/wjg.v29.i25.3932","volume":"29","author":"E Gumus","year":"2023","unstructured":"Gumus E, Ozen H (2023) Glycogen storage diseases: an update. World J Gastroenterol 29(25):3932\u20133963. https:\/\/doi.org\/10.3748\/wjg.v29.i25.3932","journal-title":"World J Gastroenterol"},{"issue":"11","key":"672_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A et al (2014) Diagnosis and management of glycogen storage disease type I: a practice guideline of the American college of medical genetics and genomics. Genet Med 16(11):e1. https:\/\/doi.org\/10.1038\/gim.2014.128","journal-title":"Genet Med"},{"key":"672_CR7","doi-asserted-by":"publisher","first-page":"1128581","DOI":"10.3389\/fimmu.2023.1128581","volume":"14","author":"D Krzyzanowski","year":"2023","unstructured":"Krzyzanowski D, Oszer A, Madzio J, Zdunek M, Kolodrubiec J, Urbanski B et al (2023) The paradox of autoimmunity and autoinflammation in inherited neutrophil disorders - in search of common patterns. Front Immunol 14:1128581. https:\/\/doi.org\/10.3389\/fimmu.2023.1128581","journal-title":"Front Immunol"},{"key":"672_CR8","doi-asserted-by":"publisher","unstructured":"Veiga-da-Cunha M, Wortmann SB, Grunert SC, Van Schaftingen E (2023) Treatment of the neutropenia associated with GSD1b and G6PC3 deficiency with SGLT2 inhibitors. Diagnostics (Basel) 13(10). https:\/\/doi.org\/10.3390\/diagnostics13101803","DOI":"10.3390\/diagnostics13101803"},{"issue":"4","key":"672_CR9","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1073\/pnas.1816143116","volume":"116","author":"M Veiga-da-Cunha","year":"2019","unstructured":"Veiga-da-Cunha M, Chevalier N, Stephenne X, Defour JP, Paczia N, Ferster A et al (2019) Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc Natl Acad Sci U S A 116(4):1241\u20131250. https:\/\/doi.org\/10.1073\/pnas.1816143116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"672_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1023\/a:1005677912539","volume":"23","author":"K Ihara","year":"2000","unstructured":"Ihara K, Nomura A, Hikino S, Takada H, Hara T (2000) Quantitative analysis of glucose-6-phosphate translocase gene expression in various human tissues and Haematopoietic progenitor cells. J Inherit Metab Dis 23(6):583\u2013592. https:\/\/doi.org\/10.1023\/a:1005677912539","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"672_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00018-023-04884-8","volume":"80","author":"J Diederich","year":"2023","unstructured":"Diederich J, Mounkoro P, Tirado HA, Chevalier N, Van Schaftingen E, Veiga-da-Cunha M (2023) SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia. Cell Mol Life Sci 80(9):259. https:\/\/doi.org\/10.1007\/s00018-023-04884-8","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"672_CR12","doi-asserted-by":"publisher","first-page":"11968","DOI":"10.1038\/s41598-017-12210-z","volume":"7","author":"L Ying","year":"2017","unstructured":"Ying L, He X, Ma X, Shen Y, Su H, Peng J et al (2017) Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population. Sci Rep 7(1):11968. https:\/\/doi.org\/10.1038\/s41598-017-12210-z","journal-title":"Sci Rep"},{"issue":"6","key":"672_CR13","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1002\/ctm2.470","volume":"11","author":"BA Kappel","year":"2021","unstructured":"Kappel BA, Moellmann J, Thiele K, Rau M, Artati A, Adamski J et al (2021) Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker. Clin Transl Med 11(6):e470. https:\/\/doi.org\/10.1002\/ctm2.470","journal-title":"Clin Transl Med"},{"issue":"9","key":"672_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1182\/blood.2019004465","volume":"136","author":"SB Wortmann","year":"2020","unstructured":"Wortmann SB, Van Hove JLK, Derks TGJ, Chevalier N, Knight V, Koller A et al (2020) Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood 136(9):1033\u20131043. https:\/\/doi.org\/10.1182\/blood.2019004465","journal-title":"Blood"},{"issue":"11","key":"672_CR15","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1182\/bloodadvances.2023012403","volume":"8","author":"M Kaczor","year":"2024","unstructured":"Kaczor M, Malicki S, Folkert J, Dobosz E, Bryzek D, Chruscicka-Smaga B et al (2024) Neutrophil functions in patients with neutropenia due to glycogen storage disease type 1b treated with empagliflozin. Blood Adv 8(11):2790\u20132802. https:\/\/doi.org\/10.1182\/bloodadvances.2023012403","journal-title":"Blood Adv"},{"issue":"7","key":"672_CR16","doi-asserted-by":"publisher","first-page":"e27264","DOI":"10.7759\/cureus.27264","volume":"14","author":"K Makrilakis","year":"2022","unstructured":"Makrilakis K, Barmpagianni A, Veiga-da-Cunha M (2022) Repurposing of empagliflozin as a possible treatment for neutropenia and inflammatory bowel disease in glycogen storage disease type Ib: A case report. Cureus 14(7):e27264. https:\/\/doi.org\/10.7759\/cureus.27264","journal-title":"Cureus"},{"issue":"3","key":"672_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1023\/a:1015602601091","volume":"25","author":"PJ Lee","year":"2002","unstructured":"Lee PJ (2002) Growing older: the adult metabolic clinic. J Inherit Metab Dis 25(3):252\u2013260. https:\/\/doi.org\/10.1023\/a:1015602601091","journal-title":"J Inherit Metab Dis"},{"key":"672_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/8904_2016_38","volume":"36","author":"EM Wong","year":"2017","unstructured":"Wong EM, Lehman A, Acott P, Gillis J, Metzger DL, Sirrs S (2017) Hypogonadotropic hypogonadism in males with glycogen storage disease type 1. JIMD Rep 36:79\u201384. https:\/\/doi.org\/10.1007\/8904_2016_38","journal-title":"JIMD Rep"},{"issue":"1","key":"672_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10545-012-9490-1","volume":"36","author":"A Sechi","year":"2013","unstructured":"Sechi A, Deroma L, Lapolla A, Paci S, Melis D, Burlina A et al (2013) Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study. J Inherit Metab Dis 36(1):83\u201389. https:\/\/doi.org\/10.1007\/s10545-012-9490-1","journal-title":"J Inherit Metab Dis"},{"issue":"0 3","key":"672_CR20","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1007\/s10545-010-9054-1","volume":"33","author":"AI Dagli","year":"2010","unstructured":"Dagli AI, Lee PJ, Correia CE, Rodriguez C, Bhattacharya K, Steinkrauss L et al (2010) Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries. J Inherit Metab Dis 33(0 3):S151\u2013S157. https:\/\/doi.org\/10.1007\/s10545-010-9054-1","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"672_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2169\/internalmedicine.39.663","volume":"39","author":"T Abe","year":"2000","unstructured":"Abe T, Azuma H, Watanabe A, Shigekiyo T, Endou S, Pou R et al (2000) A patient with Cyclic neutropenia complicated by severe persistent neutropenia successfully delivered a healthy baby. Intern Med 39(8):663\u2013666. https:\/\/doi.org\/10.2169\/internalmedicine.39.663","journal-title":"Intern Med"},{"issue":"4","key":"672_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000292355","volume":"40","author":"R Fujiwaki","year":"1995","unstructured":"Fujiwaki R, Hata T, Hata K, Kitao M, Furuya H, Katoh Y (1995) Effective treatment of drug-induced agranulocytosis using Recombinant human granulocyte colony stimulating factor in pregnancy. GynecolObstet Invest 40(4):276\u2013277. https:\/\/doi.org\/10.1159\/000292355","journal-title":"GynecolObstet Invest"},{"issue":"2","key":"672_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/humrep\/13.2.498","volume":"13","author":"SJ Kaufmann","year":"1998","unstructured":"Kaufmann SJ, Sharif K, Sharma V, McVerry BA (1998) Term delivery in a woman with severe congenital neutropenia, treated with growth colony stimulating factor. Hum Reprod 13(2):498\u2013499. https:\/\/doi.org\/10.1093\/humrep\/13.2.498","journal-title":"Hum Reprod"},{"issue":"4","key":"672_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jmd2.12295","volume":"63","author":"SC Grunert","year":"2022","unstructured":"Grunert SC, Rosenbaum-Fabian S, Schumann A, Selbitz AC, Merz W, Gieselmann A et al (2022) Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib. JIMD Rep 63(4):303\u2013308. https:\/\/doi.org\/10.1002\/jmd2.12295","journal-title":"JIMD Rep"},{"issue":"7","key":"672_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00592-018-1134-y","volume":"55","author":"G Formoso","year":"2018","unstructured":"Formoso G, Ginestra F, Di Dalmazi G, Consoli A (2018) Empagliflozin, Metformin and insulin Degludec, during pregnancy: a case report. Acta Diabetol 55(7):759\u2013761. https:\/\/doi.org\/10.1007\/s00592-018-1134-y","journal-title":"Acta Diabetol"},{"key":"672_CR26","doi-asserted-by":"publisher","first-page":"1215356","DOI":"10.3389\/fendo.2023.1215356","volume":"14","author":"DRP Muller","year":"2023","unstructured":"Muller DRP, Stenvers DJ, Malekzadeh A, Holleman F, Painter RC, Siegelaar SE (2023) Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence. Front Endocrinol (Lausanne) 14:1215356. https:\/\/doi.org\/10.3389\/fendo.2023.1215356","journal-title":"Front Endocrinol (Lausanne)"},{"key":"672_CR27","doi-asserted-by":"publisher","unstructured":"Abdelzaher WY, De Waard M, Abdelmonaem AA, Ali DM, El-Tahawy NFG, Rifaai RA et al (2023) Empagliflozin protects against haloperidol Experimentally-Induced ovarian toxicity. Pharmaceuticals (Basel) 16(2). https:\/\/doi.org\/10.3390\/ph16020168","DOI":"10.3390\/ph16020168"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00672-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-025-00672-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00672-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T03:24:50Z","timestamp":1760066690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-025-00672-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["672"],"URL":"https:\/\/doi.org\/10.1007\/s42000-025-00672-0","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}